Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: C02KX02

Ambrisentan Zentiva(ambrisentan)

Hypertension, Pulmonary

Marketing Authorisation Holder: Zentiva, k.s.

INN: ambrisentan

Indication

Treatment of pulmonary arterial hypertension.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ambrisentan Zentiva — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.